In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Practice Guideline Track on Valvular Heart Disease

Guidelines into Practice

CV Surgery - Valves
Valvular Heart Disease
Non-coronary Cardiac Intervention


Contributors:  Special thanks to Helmut Baumgartner

Based on the 2017 ESC Guidelines on the Management of Valvular Heart Disease

Webinars on this topic

14 December 2017:  ESC Webinar "The year 2017 in cardiology: A resume of the most impactful innovations in prevention, heart failure, arrhythmias and valvular heart disease" - Watch the recording

Overview of the Guidelines

Session title Slides Webcasts
Valvular heart disease - Volkmar FALK (Berlin, Germany) Helmut BAUMGARTNER (Muenster, Germany)    
Aortic valve disease. Helmut BAUMGARTNER (Muenster, Germany)    
Mitral valve disease. Raphael ROSENHEK (Vienna, Austria)    
Tricuspid valve disease. Michele DE BONIS (Milano, Italy)    
Prosthetic valves. Bernard IUNG (Paris Cedex 18, France)    

Topics in focus

Topics Session title Slides Webcasts
Clinical decisions in aortic stenosis Treatment decisions in aortic valve stenosis - Asymptomatic severe aortic stenosis. Philippe GENEREUX (Montreal, Canada)    
Clinical decisions in aortic stenosis Treatment decisions in aortic valve stenosis -Low flow/low gradient aortic stenosis. Philippe PIBAROT (Quebec, Canada)    
Clinical decisions in aortic stenosis Treatment decisions in aortic valve stenosis - Moderate aortic stenosis and heart failure. Nicolas VAN MIEGHEM (Rotterdam, Netherlands    
Clinical decisions in aortic stenosis Treatment decisions in aortic valve stenosis - Aortic stenosis with concomitant mitral regurgitation. William ZOGHBI (Houston, United States of America)    
Clinical decisions in aortic stenosis Hypertension and aortic stenosis - What do the guidelines say? Thomas H MARWICK (Melbourne, Australia)    
Clinical decisions in aortic stenosis Hypertension and aortic stenosis. How to implement Guidelines – Panel discussion Eva GERDTS (Bergen, NO), Tatiana KUZNETSOVA (Leuven, BE)    
Decisions around TAVI Current patient selection criteria for TAVR/TAVI: what the trials and experience tell us Martin B LEON (New York, United States of America)    
Decisions around TAVI When is TAVI futile? Catherine M OTTO (Seattle, United States of America)    
Decisions around TAVI TAVI with atrial fibrillation: which antithrombotic regimen? Gilles MONTALESCOT (Paris, France)    
Decisions around TAVI Coronary artery disease in TAVI, if and when to treat? Kentaro HAYASHIDA (Tokyo, Japan)    
Decisions around TAVI An intermediate-risk patient with symptomatic severe aortic stenosis. Helene ELTCHANINOFF (Rouen Cedex, France)    
Decisions around TAVI An intermediate-risk patient with symptomatic severe aortic stenosis - What do the guidelines say?    
Decisions around TAVI An intermediate-risk patient with symptomatic severe aortic stenosis - Conclusion and take home message. Stephan BALDUS (Koln, Germany)    
Decisions around TAVI Post TAVI/TAVR care with a focus on anticoagulation and antithrombotics Samir R KAPADIA (Cleveland, United States of America)    
Clinical decisions in mitral regurgitation Secondary mitral regurgitation: when to perform percutaneous repair. Joerg HAUSLEITER (Muenchen, Germany)    
Clinical decisions in mitral regurgitation The when and how of surgery for secondary mitral regurgitation Ottavio ALFIERI (Milano, Italy)    
Clinical decisions in mitral regurgitation A frail elderly patient with primary mitral regurgitation. Joer KEMPFERT (Berlin, Germany)    
Tricuspid valve management State of the Art: tricuspid valve - Still the forgotten valve? Maurice Lionel ENRIQUEZ-SARANO (Rochester, United States of America)